| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/15/2011 | US7906142 Agropolymer material for use in water purification and a method of producing the same |
| 03/15/2011 | US7906141 Sustained-release, oral pharmaceutical forms of formulation |
| 03/15/2011 | US7906140 Compositions for mucosal delivery of agents |
| 03/15/2011 | US7906139 phosphatidylcholine, sphingomyelin, phosphatidyl ethanolamine, phosphatidyl serine, phosphatidyl inositol, and cholesterol; for removal of extra-/intra- vascular fibrin clots/adhesions; for use during surgery; for treatment of otitis |
| 03/15/2011 | US7906138 Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses |
| 03/15/2011 | US7906137 Delivery agents for enhancing mucosal absorption of therapeutic agents |
| 03/15/2011 | US7906126 Adhesive block ethylenic copolymers, cosmetic compositions containing them and cosmetic use of these copolymers |
| 03/15/2011 | US7906125 a biodisintegrable binder (e.g., a biodisintegrable polymer or organic compound) and a chemical ablation agent (e.g., a salt), effective to cause tissue necrosis; injectable or insertable dosage forms; chemoablation of tissue, such as prostate |
| 03/15/2011 | US7905878 Implantable pump with reservoir level detector |
| 03/15/2011 | US7905724 Methods and systems for concurrent tooth repositioning and substance delivery |
| 03/15/2011 | CA2595003C Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof |
| 03/15/2011 | CA2577740C Method of enhancing absorptions of transmucosal administration formulations |
| 03/15/2011 | CA2566331C Oral delivery system |
| 03/15/2011 | CA2550660C Florfenicol prodrug having improved water solubility |
| 03/15/2011 | CA2502220C Transdermal patch for external use comprising fentanyl |
| 03/15/2011 | CA2496780C Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same |
| 03/15/2011 | CA2470703C Oral pharmaceutical products containing 17.beta.-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| 03/15/2011 | CA2469174C Emulsifier for highly liquid w/o emulsions based on partly crosslinked polyglycerol esters of polyhydroxystearic acid |
| 03/15/2011 | CA2463681C Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent |
| 03/15/2011 | CA2459459C Drug delivery technology |
| 03/15/2011 | CA2451718C Sustained-release composition comprising lactic acid-glycolic acid copolymer and process for producing the same |
| 03/15/2011 | CA2443586C Methods of forming shaped articles from suspensions |
| 03/15/2011 | CA2443235C Pharmaceutical compositions comprising ascomycin |
| 03/15/2011 | CA2434169C Spaced drug delivery system |
| 03/15/2011 | CA2426921C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 03/15/2011 | CA2412776C Compositions controlling release ph range and/or speed |
| 03/15/2011 | CA2406064C Minimizing adverse experience associated with oxybutynin therapy |
| 03/15/2011 | CA2406008C Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
| 03/15/2011 | CA2404196C Medical emulsion for lubrication and delivery of drugs |
| 03/15/2011 | CA2392006C Microfabricated devices for the delivery of molecules into a carrier fluid |
| 03/15/2011 | CA2389302C Delivery of proteins across polar epithelial cell layers |
| 03/15/2011 | CA2383284C Use of ribose to prevent cramping and soreness in muscles |
| 03/15/2011 | CA2302508C Polyanhydrides with therapeutically useful degradation products |
| 03/10/2011 | WO2011029059A1 Use of aerosolized levofloxacin for treating cystic fibrosis |
| 03/10/2011 | WO2011029028A2 Targeted delivery using tissue-specific peptidomimetic ligands |
| 03/10/2011 | WO2011029016A1 Compositions and methods for delivering rnai using apoe |
| 03/10/2011 | WO2011028850A1 Delivery of therapeutic agents using oligonucleotide-modified nanoparticles as carriers |
| 03/10/2011 | WO2011028847A1 Polyvalent polynucleotide nanoparticle conjugates as delivery vehicles for a chemotherapeutic agent |
| 03/10/2011 | WO2011028799A2 Ganglioside transmucosal formulations |
| 03/10/2011 | WO2011028718A1 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 03/10/2011 | WO2011028673A2 A composition for delaying cellular senescence |
| 03/10/2011 | WO2011028629A1 Pharmaceutical formulations and methods of use |
| 03/10/2011 | WO2011028495A1 Hot-melt extruded compositions containing plant-derived phenolic materials and processes for the preparation thereof |
| 03/10/2011 | WO2011028416A2 Oral medication for the treatment of hemorrhoids and method of use |
| 03/10/2011 | WO2011028406A2 Soaking agent for the treatment of hemorrhoids and method of use |
| 03/10/2011 | WO2011028334A2 Synthesis and isolation of dendrimer systems |
| 03/10/2011 | WO2011028278A1 Extended use medical device |
| 03/10/2011 | WO2011028234A1 Uses of acyloxyalkyl carbamate prodrugs of tranexamic acid |
| 03/10/2011 | WO2011028110A1 Composition for topical application, uses thereof, applicator device and kit of parts |
| 03/10/2011 | WO2011028016A2 Pharmaceutical preparation comprising beta-adrenergic blockers and angiotensin ii receptor blockers |
| 03/10/2011 | WO2011027990A2 Extracellular vesicles derived from gram-positive bacteria, and use thereof |
| 03/10/2011 | WO2011027795A1 Preparation for oral administration |
| 03/10/2011 | WO2011027786A1 Transdermally absorbable preparation |
| 03/10/2011 | WO2011027778A1 Composition for topical administration to eyes for use in treatment of ocular hypertension and glaucoma |
| 03/10/2011 | WO2011027729A1 Hydroxypropyl cellulose particles |
| 03/10/2011 | WO2011027728A1 Coating agent comprising hydroxyalkyl cellulose |
| 03/10/2011 | WO2011027684A1 Apparatus and method for production of liposomes |
| 03/10/2011 | WO2011027605A1 Liquid composition to be filled in soft capsules |
| 03/10/2011 | WO2011027373A1 Composition containing ultra-micronized palmitoyl - ethanolamide |
| 03/10/2011 | WO2011027365A2 Ophthalmic compositions containing dorzolamide, timolol and brimonidine |
| 03/10/2011 | WO2011027346A1 A gastroretentive dosage form for oral treatment of domestic animals |
| 03/10/2011 | WO2011027333A1 Granulated anthelmintic preparations and delivery systems |
| 03/10/2011 | WO2011027322A1 Extended release dosage form containing olopatadine for oral administration |
| 03/10/2011 | WO2011027258A2 Scented capsules |
| 03/10/2011 | WO2011027248A1 Oral liquid formulation comprising salbutamol and guaifenesin |
| 03/10/2011 | WO2011027247A1 An antifungal cream comprising terbinafine hydrochloride |
| 03/10/2011 | WO2011027246A1 A cream comprising miconazole nitrate and a biopolymer for the treatment of diaper rash |
| 03/10/2011 | WO2011027174A2 Composition |
| 03/10/2011 | WO2011027060A2 Oxytocin treatment for behavioral characteristics associated with autism and shyness disorder |
| 03/10/2011 | WO2011026896A1 Method and apparatus for preparing micro-particles of polysaccharides |
| 03/10/2011 | WO2011026808A1 Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles |
| 03/10/2011 | WO2011026401A1 Anti-tumor natural medicines coupled with nitric oxide donors and pharmaceutical uses thereof |
| 03/10/2011 | WO2011026312A1 Novel matrix slow release tablet containing metoprolol succinate |
| 03/10/2011 | WO2011026267A1 Antiphlogistic, antioncotic and analgesic chinese herbal composition,preparative method and usage thereof |
| 03/10/2011 | WO2011026234A1 Clarithromycin extended-release tablet |
| 03/10/2011 | WO2011007153A8 Improvements in and relating to colon cleansing compositions |
| 03/10/2011 | WO2011002857A3 3-cyanoquinoline tablet formulations and uses thereof |
| 03/10/2011 | WO2010146601A4 Rapid dissolvable oral film for delivering herbal extract/s with or without other pharmaceutically active agents |
| 03/10/2011 | WO2010141586A3 Therapeutic ophthalmic emulsions |
| 03/10/2011 | WO2010130462A8 Phosphate-free pharmaceutical composition for the treatment of glaucoma |
| 03/10/2011 | WO2010130418A3 Treatment of eye diseases using encapsulated cells encoding and secreting a neuroprotective factor and/or an anti-angiogenic factor |
| 03/10/2011 | WO2010127205A3 Fixed dose drug combination formulations |
| 03/10/2011 | WO2010106555A3 Directly compressible pre-granulated cellulose ether polymer and process for preparing the same |
| 03/10/2011 | WO2010087986A3 Resuscitation fluid |
| 03/10/2011 | WO2010068281A3 Contact lens drug delivery device |
| 03/10/2011 | WO2010015298A3 Crystalline active ingredient microparticles, method for producing the same and use thereof in drugs |
| 03/10/2011 | US20110060412 Tissue Engineered Meniscus Repair Composition |
| 03/10/2011 | US20110060318 Methods and systems for providing metered doses of a compound to an individual |
| 03/10/2011 | US20110060310 Intracutaneous injection |
| 03/10/2011 | US20110060195 Cosmetic treatment method for treating the scalp |
| 03/10/2011 | US20110060032 Lipid encapsulating interfering rna |
| 03/10/2011 | US20110060016 Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient |
| 03/10/2011 | US20110059927 Calcium Formate For Use As A Dietary Supplement |
| 03/10/2011 | US20110059897 Methods for treating a skin wound |
| 03/10/2011 | US20110059226 Method for loading a molecule into a porous substrate |
| 03/10/2011 | US20110059183 Water-insoluble medicine |
| 03/10/2011 | US20110059182 Spraying device and related method for cell aggregates and cell aggregate suspension thereof |
| 03/10/2011 | US20110059181 Methods for drug delivery comprising unfolding and folding proteins and peptide nanoparticles |
| 03/10/2011 | US20110059180 Method for Preparing Nanoparticles Based on Functional Amphiphilic Molecules or Macromolecules, and the Use Thereof |
| 03/10/2011 | US20110059179 controlled delivery system that provides malodor management over a prolonged period of time |